GlassScriptPhysician profile
Michael Dillenkofer
NPI 1861075095
$7,991.66
in general payments reported to CMS, 2019-2025
19 companies · $3,376 in 2025
The $3,376 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $432 · 2022: $692 · 2023: $437 · 2024: $3,054 · 2025: $3,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,898 · Travel and Lodging: $1,969 · Grant: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,897.60 |
| Travel and Lodging | $1,969.37 |
| Grant | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,364.11 | 2021-2025 | Insignia, Mako, Pangea |
| Zimmer Biomet Holdings, INC. | $1,327.78 | 2021-2025 | Rosa |
| Acumed LLC | $955.80 | 2025 | Acumed |
| Aroa Biosurgery Incorporated | $832.51 | 2025 | |
| Polynovo North America LLC | $404.45 | 2022-2025 | Novosorb Btm |
| Sanara Medtech INC. | $400.93 | 2023-2024 | Celleraterx |
| Si-Bone, INC. | $370.20 | 2021-2023 | |
| Kuros Biosciences USA, INC | $310.32 | 2024-2025 | Magnetos |
| Smith+Nephew, INC. | $252.12 | 2021-2025 | Cadence, Panta 2 |
| Integra Lifesciences Corporation | $147.59 | 2022 | |
| Microport Orthopedics INC | $134.44 | 2024 | Mpo Medial Pivot Knee |
| Treace Medical Concepts, INC. | $123.14 | 2025 | |
| Axogen | $118.85 | 2025 | |
| Naviswiss, INC. | $95.04 | 2025 | Naviswiss Hip/Knee Navigation |
| Novus Surgical Consultants | $53.42 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $38.22 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Restor3d, INC. | $36.06 | 2022 | |
| Depuy Synthes Sales INC. | $17.88 | 2024 | Na |
| Biocomposites INC | $8.80 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dillenkofer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.